|
⚲
|
| Keyboard |
| SR One Capital Management LLC
✚
|
|
|---|---|
| CIK # | 0001910264, 0001853723 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Veradermics Inc | 151.7 | ||
| Zenas Biopharma Inc | 98.5 | ||
| CRISPR Therapeutics AG | 97.0 | ||
| Design Therapeutics Inc | 69.4 | ||
| Oric Pharmaceuticals Inc | 58.5 | ||
| Alumis Inc | 43.2 | ||
| Mineralys Therapeutics Inc | 42.4 | ||
| Silverback Therapeutics Inc | 32.2 | ||
| ARCA Biopharma Inc | 21.1 | ||
| Oculis Holding AG | 17.0 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001853723] | |
| 4 | [0001853723] | |
| SC 13D | [0001853723] | |
| SC 13G | [0001853723] | |
| 13F-HR | [0001910264] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2025-10-09 | Buy | 63,157 | $19.00 | 1,199,983 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2025-10-09 | Buy | 63,158 | $19.00 | 1,200,002 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Buy | 441,176 | $17.00 | 7,499,992 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Conversion | 1,505,388 | ||
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Buy | 1,352,942 | $17.00 | 23,000,014 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Conversion | 501,796 | ||
|
Zenas BioPharma Inc ZBIO
Series C Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 5,809,528 | ||
|
Zenas BioPharma Inc ZBIO
Series C Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 4,357,146 | ||
|
Zenas BioPharma Inc ZBIO
Series C Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 13,071,439 | ||
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Buy | 441,176 | $17.00 | 7,499,992 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Conversion | 669,061 | ||
|
eFFECTOR Therapeutics Inc EFTR
Common Stock
|
2023-11-27 | Sell | 178,585 | $0.61 | 108,937 |
|
eFFECTOR Therapeutics Inc EFTR
Common Stock
|
2023-11-27 | Sell | 430,578 | $0.61 | 262,653 |
|
Arcellx Inc ACLX
Common Stock
|
2023-05-11 | Sell | 3,804 | $46.15 | 175,555 |
|
Arcellx Inc ACLX
Common Stock
|
2023-05-11 | Sell | 6,485 | $46.15 | 299,283 |
|
Arcellx Inc ACLX
Common Stock
|
2023-05-11 | Sell | 631,932 | $45.00 | 28,436,940 |
|
Arcellx Inc ACLX
Common Stock
|
2023-05-11 | Sell | 370,612 | $45.00 | 16,677,540 |
|
Design Therapeutics Inc DSGN
Common Stock
|
2022-12-20 | Buy | 40,000 | $8.14 | 325,600 |
|
Design Therapeutics Inc DSGN
Common Stock
|
2022-12-19 | Buy | 360,000 | $8.63 | 3,106,800 |
|
Design Therapeutics Inc DSGN
Common Stock
|
2022-12-16 | Buy | 500,000 | $8.28 | 4,140,000 |
| showing 20 of 37 most recent transactions | |||||